The menopausal hot flush-Anything new?

Maturitas

Volumn 60, Issue 1, 2008, Pages 42-49

  Sturdee, David W ^a  

^a SOLIHULL HOSPITAL   (United Kingdom)

Author keywords

Hot flush; Mechanism; Physiology; Treatments

Indexed keywords

ENDORPHIN; ESTROGEN; GABAPENTIN; GESTAGEN; GONADOTROPIN; LUTEINIZING HORMONE; PAROXETINE; PHYTOESTROGEN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ALTERNATIVE MEDICINE; CLINICAL FEATURE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LIFESTYLE MODIFICATION; MENOPAUSAL SYNDROME; PHYSIOLOGY; PREVALENCE; REVIEW;

ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HOT FLASHES; HUMANS; HYPOTHALAMUS; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGED; PHYTOESTROGENS;

EID: 45649083485     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.02.006     Document Type: Review

References (54)

1. Oldenhave A., Jaszmann L.J., Haspels A.A., and Everaerd W.T. Impact of climacteric on well-being. A survey based on 5213 women 39-60 yrs old. Am J Obstet Gynecol 168 (1993) 772-780
2. Beyene Y., and Martin M.C. Menopausal experiences and bone density of Mayan women in Yucatan, Mexico. Am J Hum Biol 13 (2001) 505-511
3. Freeman E.W., and Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 10 (2007) 197-214
4. Albery N. The menopause in Japan-konenki jigoku. Climacteric 2 (1999) 160-161
5. Anderson D., Yoshizawa T., Gollschewski S., Atogami F., and Courtney M. Menopause in Australia and Japan: effects of country of residence on menopausal status and menopausal symptoms. Climacteric 7 (2004) 165-174
6. Appling S., Paez K., and Allen J. Ethnicity and vasomotor symptoms in postmenopausal women. J Women's Health 16 (2007) 1130-1138
7. Crandall C.J., Crawford S.L., and Gold E.B. Vasomotor symptom prevalence is associated with polymorphisms in sex-steroid metabolising enzymes and receptors. Am J Med 119 9 Suppl. 1 (2006) s52-s60
8. Thurston R.C., Sowers M.R., Chang Y., et al. Adiposity and reporting of vasomotor symptoms among midlife women: the study of Women's Health Across the Nation. Am J Epidemiol (September 19, 2007) [E Pub ahead of print]
9. Sievert L.L., and Flanagan E.K. Geographical distribution of hot flash frequencies: considering climatic influences. Am J Phys Anthropol 128 (2005) 437-443
10. Voda A.M. Climacteric hot flash. Maturitas 3 (1981) 73-90
11. Sturdee DW. Biological responses to the female climacteric and oestrogen-progestogen therapy. MD Thesis. University of Birmingham; 1979.
12. Tataryan I.V., Lomax P., Bajorek J.G., et al. Postmenopausal hot flushes: a disorder of thermoregulation. Maturitas 2 (1980) 101-107
13. Erlik Y., Tataryan I.V., Meldrum D.R., et al. Association of waking episodes with menopausal hot flushes. J Am Med Assoc 245 (1981) 1741-1744
14. Freedman R.R., and Roehrs T.A. Effects of REM sleep and ambient temperature on hot flash-induced sleep disturbance. Menopause 13 (2006) 576-583
15. Kronenberg F. Hot Flashes: epidemiology and physiology. Ann NY Acad Sci 592 (1990) 52-86
16. Molnar G.W. Body temperatures during menopausal hot flashes. J Appl Physiol 38 (1975) 499-503
17. Sturdee D.W., and Reece B.L. Thermography of menopausal hot flushes. Maturitas 1 (1979) 201-205
18. Tataryn I.V., Meldrum D.R., Lu K.H., Frumar A.M., and Judd H.L. LH, FSH and skin temperature during the menopausal hot flush. J Clin Endocrinol Metab 49 (1979) 152-154
19. Kronenberg F., Cote L.J., Linkie D.M., Dyrenfurther I., and Downey J.A. Menopausal hot flashes: thermoregulatory, cardiovascular and circulating catecholamine and LH changes. Maturitas 6 (1984) 31-43
20. Sturdee D.W., Wilson K.A., Pipili E., and Crocker A.D. Physiological aspects of menopausal hot flush. Br Med J 2 (1978) 79-80
21. Silverman R.W., Bajorek J.G., Lomax P., and Tataryn I.V. Monitoring the pathophysiological correlates of postmenopausal hot flushes. Maturitas 3 (1981) 39-46
22. Freedman R.R., and Wasson S. Miniature hygrometric hot flash recorder. Fertil Steril 88 (2007) 494-496
23. Schoenbaum E. Animal models of postmenopausal hot flushes. In: Lomax P., and Vessel E.S. (Eds). The Climacteric Hot Flush. Progress in Basic and Clinical Pharmacology (1991), Karger 108-118
24. MacLennan A.H., Lester S., and Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric 4 (2001) 58-74
25. Freedman R.R. Pathophysiology and treatment of hot flashes. Semin Reprod Med 23 (2005) 117-125
26. Campbell S, Breeson AJ, Kitchin Y, Fergusson IK, Biswas S. Intensive steroid and protein hormone profiles on postmenopausal women experiencing hot flushes, and a group of controls. In: Campbell S, editor. The management of the menopause and postmenopausal years. Lancaster: MTP Press Ltd.; in press. p. 63-77.
27. Hutton J.D., Jacobs H.S., Murray M.F., and James V.H.T. Relationship between plasma oestrone and oestradiol and climacteric symptoms. Lancet 1 (1978) 678-681
28. Meldrum D.R., Erlik Y., Lu J.K.H., and Judd H.L. Objectively recorded hot flushes in patients with pituitary insufficiency. J Clin Endocrinol Metab 52 (1981) 684-687
29. Meldrum D.R., Tataryan I.V., Frumar A., and Gonadotrophins M.E. estrogens and adrenal steroids during the menopausal hot flash. J Clin Endocrinol Metab 50 (1980) 685-689
30. Shaw R.W., Kerr-Wilson R.H.J., Fraser H.M., et al. The effect of an intranasal LHRH agonist on gonadotrophins and hot flushes in postmenopausal women. Maturitas 7 (1985) 161-167
31. Simpkins J.W., and Kalra S.P. Central sites of norepinephrine and LHRH interaction. Fed Proc 38 (1979) 1107
32. Berendsen H.H.G. The role of serotonin in hot flushes. Maturitas 36 (2000) 155-164
33. Nelson H.D., Vesco K.K., Haney E., et al. Non-hormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 295 (2006) 2057-2071
34. Reddy S.Y., Warner H., Guttoso Jr. T., et al. Gabapentin, estrogen and placebo for treating hot flushes: a randomised controlled trial. Obstet Gynecol 108 (2006) 4-5
35. Pandya K.J., Morrow G.R., Roscoe J.A., et al. Gabapentin for hot flushes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 366 (2005) 818-824
36. Unfer V., Casini M., Costabile L., et al. Endometrial effects of long-term treatment with phytoestrogens: a randomised, double-blind, placebo-controlled study. Fertil Steril 82 (2004) 145-148
37. Pockaj B.A., Gallagher J.G., Loprinzi C.L., et al. Phase III double-blind, randomised, placebo-controlled crossover trial of Black cohosh in the management of hot flashes. J Clin Oncol 24 (2006) 2836-2841
38. Levitsky J., Alli T.A., Wisecorner J., and Sorrell M.E. Fulminate liver failure associated with the use of Black cohosh. Dig Dis Sci 50 (2005) 538-539
39. Lynch C.R., Folkers M.E., and Hutson W.R. Fulminating hepatic failure associated with the use of Black Cohosh: a case report. Liver Transplant 12 (2006) 989-992
40. Hickey M., Saunders C.M., and Stuckey B.G. Non-hormonal treatments for menopausal symptoms. Maturitas 57 (2007) 85-89
41. Alfhaily F., and Ewies A.A.A. Acupuncture in imaging menopausal symptoms: hope or mirage. Climacteric 10 (2007) 371-380
42. Sturdee D.W., and MacLennan A.H. Not all placebos are equally pleasing. Climacteric 9 (2006) 401-403
43. Ernst E. Placebo, deceit and complementary/alternative medicine. Climacteric 10 (2007) 85-87
44. Grady D. Management of menopausal symptoms. N Engl J Med 355 (2006) 2338-2347
45. Utian W.H., Shoupe D., Bachmann G., Pinkerton J.V., and Pickar J.H. Relief of vasomotor symptoms and vaginal atrophy with the lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 75 (2001) 1065-1079
46. Panay N., Ylikorkala O., Archer D.F., Gut R., and Lang E. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric 10 (2007) 120-131
47. Bachmann G.A., Schaefors M., Uddin A., and Utian W.H. Lowest effective transdermal 17β-estradiol dose for relief of hot flushes in postmenopausal women: a randomised controlled trial. Obstet Gynecol 110 (2007) 770-779
48. Paterson M.E.L. A randomised double-blind cross-over trial into the effect of norethisterone on climacteric symptoms and biochemical profiles. Brit J Obstet Gynaecol 89 (1982) 464-472
49. Farish E., Barnes J.F., O'Donoghue F., et al. The role of megestrol acetate as an alternative to conventional hormone replacement therapy. Climacteric 3 (2000) 125-134
50. Loprinzi C.L., Levitt R., Barton D., et al. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. J Clin Oncol 24 (2006) 1409-1414
51. Freedman R.R., and Woodward S. Behavioural treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 167 (1992) 436-439
52. The Endocrine society position statement. http://www.endo-society.org.
53. Pines A., Sturdee D.W., Birkhäuser M.H., et al., On behalf of the Board of the International Menopause Society. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 10 (2007) 181-194
54. Food and Drugs Administration. FDA News. FDA takes action against compounded menopause hormone therapy drugs. http://www.fda.gov/cder/pharmocomp/default.htm.